CUV 3.92% $15.65 clinuvel pharmaceuticals limited

Ann: Presentation Goldman Sachs Emerging Leaders Conference, page-13

  1. 1,147 Posts.
    lightbulb Created with Sketch. 18
    Clearly missed the point completely.
    $21 is further away from $40 than $28 was. Does that make sense to you? I can get back in now at 25% cheaper than where I sold.
    You also didn't answer the question. On what basis did you think a PE of 90 was justified?..and on what basis do you believe it should have kept rising from a PE of 90?
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.